IP Library › Granted Patent US 8,353,845
Granted Patent B2
US 8,353,845 · App. 13/162,017 · Granted Jan 15, 2013

Apparatus and method for delivery of an aerosol

Inventors: Michael McCawley (Morgantown, WV); Gary Gasner (Morgantown, WV); Ian Christie (Morgantown, WV); Tal Gottesman (Morgantown, WV); James Dalton (Morgantown, WV)
Assignee: Respiratory Management Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,353,845
App. No.
13/162,017
Granted
Jan 15, 2013
Kind
B2
Abstract

An apparatus for measuring lung ventilation, comprising: a pressure device to measure volume of air flow; an aerosol-generating device that provides aerosol particles to be released at a determined point in a breathing cycle; a mouthpiece with a detector that measures the concentration of aerosol particles for a given volume during the breathing cycle; and a computing device configured to provide lung ventilation data as a function of time constants.

Claims (21)

1. A method for treating an obstruction in the upper region of the lungs, the method comprising:

a. measuring pressure data and calculating volume of airflow of a breathing cycle;

b. providing a volume of penetration;

c. providing an aerosol bolus at a determined point of the breathing cycle;

d. measuring a concentration values of aerosol particles and calculating time constants from the measured aerosol concentration values;

e. repeating steps b to d using a different volume of penetration;

f. comparing the calculated time constants, in a processing device, from at least two provided volumes of penetration to determine the position of an obstruction; and

g. releasing a treatment bolus at a select point of the breathing cycle which is chosen based upon the determined position of the obstruction.

2. The method of claim 1 , wherein the select point is chosen to concentrate the treatment bolus in a selected volume of air flow determined to contact the position of the obstruction during the breathing cycle.

3. The method of claim 1 , wherein the treatment bolus comprises an active pharmaceutical.

4. A method for treating inflammation in the upper region of the lungs, the method comprising:

a. measuring pressure data and calculating volume of airflow of a breathing cycle;

b. providing a volume of penetration;

c. providing an aerosol bolus at a determined point of the breathing cycle;

d. measuring a concentration values of aerosol particles and calculating time constants from the measured aerosol concentration values;

e. repeating steps b to d using a different volume of penetration;

f. comparing the calculated time constants, in a processing device, from at least two provided volumes of penetration to determine the position of inflammation; and

g. releasing a treatment bolus at a select point of the breathing cycle which is chosen based upon the determined position of the inflammation.

5. The method of claim 4 , wherein the select point is chosen to concentrate the treatment bolus in a selected volume of air flow determined to contact the position of the inflammation during the breathing cycle.

6. The method of claim 4 , wherein the treatment bolus comprises a bronchial dilating agent.

7. The method of claim 4 , wherein the treatment bolus comprises an active pharmaceutical.

Continuity (4)
Division 12771151 · Apr 30, 2010
Division 11771479 · Jun 29, 2007
Division 10652561 · Sep 2, 2003
Related Publication 20110247611A1 · Oct 13, 2011